Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 5:12:733570.
doi: 10.3389/fneur.2021.733570. eCollection 2021.

Imaging Cognitive Impairment and Impulse Control Disorders in Parkinson's Disease

Antonio Martín-Bastida  1   2 , Manuel Delgado-Alvarado  3 , Irene Navalpotro-Gómez  4   5   6 , María Cruz Rodríguez-Oroz  1   2   7
Affiliations

Imaging Cognitive Impairment and Impulse Control Disorders in Parkinson's Disease

Antonio Martín-Bastida et al. Front Neurol. .

Abstract

Dementia and mild forms of cognitive impairment as well as neuropsychiatric symptoms (i. e., impulse control disorders) are frequent and disabling non-motor symptoms of Parkinson's disease (PD). The identification of changes in neuroimaging studies for the early diagnosis and monitoring of the cognitive and neuropsychiatric symptoms associated with Parkinson's disease, as well as their pathophysiological understanding, are critical for the development of an optimal therapeutic approach. In the current literature review, we present an update on the latest structural and functional neuroimaging findings, including high magnetic field resonance and radionuclide imaging, assessing cognitive dysfunction and impulse control disorders in PD.

Keywords: Parkinson's disease dementia (PDD); impulse control disorders (ICD); magnetic resonance imaging (MRI); mild cognitive impairment (MCI); positron emission tomography (PET); single photon computed tomography (SPECT).

PubMed Disclaimer

Conflict of interest statement

AM-B, MD-A, and IN-G declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. MR-O received financial support for her research from national and local government institutions in Spain (Carlos III Institute of Health, Navarra Government) and honoraria from Insightec, and Boston Scientific for lectures, travel and accommodation to attend scientific meetings.

References

    1. Gibb WRG, Lees AJ. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J Neurol Neurosurg Psychiatry. (1991) 54:388–96. 10.1136/jnnp.54.5.388 - DOI - PMC - PubMed
    1. Mann DMA, Yates PO. Possible role of neuromelanin in the pathogenesis of Parkinson's disease. Mech Ageing Dev. (1983) 21:193–203. 10.1016/0047-6374(83)90074-X - DOI - PubMed
    1. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sørensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol. (2003) 60:387–92. 10.1001/archneur.60.3.387 - DOI - PubMed
    1. Williams-Gray CH, Mason SL, Evans JR, Foltynie T, Brayne C, Robbins TW, et al. The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort. J Neurol Neurosurg Psychiatry. (2013) 84:1258–64. 10.1136/jnnp-2013-305277 - DOI - PubMed
    1. Hely MA, Reid WGJ, Adena MA, Halliday GM, Morris JGL. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Move Disord. (2008) 23:837–44. 10.1002/mds.21956 - DOI - PubMed

Publication types